Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Redhill Biopharma stock
Learn how to easily invest in Redhill Biopharma stock.
Redhill Biopharma Ltd is a drug manufacturers-specialty & generic business based in the US. Redhill Biopharma shares (RDHL) are listed on the NASDAQ and all prices are listed in US Dollars. Redhill Biopharma employs 201 staff and has a trailing 12-month revenue of around $83.4 million.
How to buy shares in Redhill Biopharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RDHL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Redhill Biopharma stock price (NASDAQ: RDHL)Use our graph to track the performance of RDHL stocks over time.
Redhill Biopharma shares at a glance
|Latest market close||$0.52|
|52-week range||$0.47 - $6.50|
|50-day moving average||$0.89|
|200-day moving average||$1.65|
|Wall St. target price||$7.75|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.10|
Buy Redhill Biopharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Redhill Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Redhill Biopharma price performance over time
|1 week (2022-09-21)||-14.75%|
|1 month (2022-08-29)||-46.72%|
|3 months (2022-06-29)||-38.82%|
|6 months (2022-03-29)||-81.02%|
|1 year (2021-09-29)||-88.60%|
|2 years (2020-09-29)||-94.92%|
|3 years (2019-09-27)||7.24|
|5 years (2017-09-28)||10.05|
Redhill Biopharma financials
|Revenue TTM||$83.4 million|
|Gross profit TTM||$45.3 million|
|Return on assets TTM||-21.74%|
|Return on equity TTM||-385.03%|
|Market capitalisation||$33.2 million|
TTM: trailing 12 months
Redhill Biopharma share dividends
We're not expecting Redhill Biopharma to pay a dividend over the next 12 months.
Redhill Biopharma share price volatility
Over the last 12 months, Redhill Biopharma's shares have ranged in value from as little as $0.473 up to $6.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Redhill Biopharma's is 1.8034. This would suggest that Redhill Biopharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Redhill Biopharma overview
RedHill Biopharma Ltd. , a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel. .
Frequently asked questionsWhat percentage of Redhill Biopharma is owned by insiders or institutions?
Currently 12.955% of Redhill Biopharma shares are held by insiders and 11.312% by institutions. How many people work for Redhill Biopharma?
Latest data suggests 201 work at Redhill Biopharma. When does the fiscal year end for Redhill Biopharma?
Redhill Biopharma's fiscal year ends in December. Where is Redhill Biopharma based?
Redhill Biopharma's address is: 21 Ha?arba?a Street, Tel Aviv, Israel, 6473921 What is Redhill Biopharma's ISIN number?
Redhill Biopharma's international securities identification number is: US7574681034 What is Redhill Biopharma's CUSIP number?
Redhill Biopharma's Committee on Uniform Securities Identification Procedures number is: 757468103
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert